𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neuromuscular Blockade by Immunoglobulin G from Patients with Miller Fisher Syndrome

✍ Scribed by BRIGITT BUCHWALD; JOSEF DUDEL; KLAUS V. TOYKA

Book ID
111394772
Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
494 KB
Volume
841
Category
Article
ISSN
0890-6564

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuromuscular blockade by IgG antibodies
Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: A macro-patch-clamp study
✍ Dr. Brigitte Buchwald; Klaus V. Toyka; Jürgen Zielasek; Andreas Weishaupt; Susan 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 910 KB

Guillain-Barré syndrome (GBS) is often associated with serum antibodies to glycoconjugates such as GM1 and GQ1b. The pathogenic role of these antibodies and other serum factors has not yet been clarified. We have investigated the effect of serum, plasma filtrate, and highly purified IgG and IgM from

Presynaptic effects of immunoglobulin G
Presynaptic effects of immunoglobulin G from patients with Lambert–Eaton myasthenic syndrome: Their neutralization by intravenous immunoglobulins
✍ Brigitte Buchwald; Raheleh Ahangari; Andreas Weishaupt; Klaus V. Toyka 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract Intravenous immunoglobulin (IVIg) treatment improves muscle strength in Lambert–Eaton myasthenic syndrome (LEMS), but its specific mode of action is unknown. We have delineated its mode of action on neuromuscular blocking properties of LEMS IgG. The effect of sera and purified IgG from